Cybin to Transfer U.S. Stock Exchange Listing to Nasdaq
TORONTO — Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) , a clinical-stage breakthrough pharmaceutical company committed to revolutionizing mental healthcare by developing innovative next-generation treatment options, today announced that it will voluntarily
(Financial Post, 2025-12-18T12:40:09Z)